Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance ...

The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical ...

The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...

The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, ...

Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strateg ...

Merck KGaA will sell its US CDMO business to Lonza in a deal worth hundreds of millions of Swiss francs, expanding Lonza's US manufacturing footprint and marking a strategic shift for Merck Merck KGaA ...

The agreement with the UK Health Security Agency will see the Danish vaccine manufacturer supply its MVA-BN mpox and smallpox ...

VAT relief on free medicines, £1bn in new investment and revised capital allowances give pharma manufacturers progress — but ...

A medical information response marked complete says nothing about safety information that arrives later. Before accepting an ...

New rapid sterility testing capability provides eligible products with results in approximately 3–7 days through automated, ...

The inspection supports renewal of the EU GMP certificate at the company's New Jersey site, which provides pharmaceutical analytical testing, microbiology and development services ...

AlzeCure Pharma AB (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer ...